Guillon, Gilles

Inhibition of oxytocin receptor function by direct binding of progesterone

Grazzini, E., Guillon, G., Mouillac, B., & Zingg, H. H. (1998) · Nature

Receptor Mechanisms and SignalingEstrogen and related hormone effects

Cited by 466

Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics

Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 423

Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆

MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 296

Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist

Gal, C. S.-L., Wagnon, J., Simiand, J., Griebel, G., Lacour, C., Guillon, G., Barberis, C., Brossard, G., Soubrié, P., Nisato, D., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 211

[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors

Derick, S., Cheng, L. L., Voirol, M. J., Stoev, S., Giacomini, M., Wo, N. C., Szeto, H. H., Ben Mimoun, M., Andres, M., Gaillard, R. C., et al. (2002) · Endocrinology

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 76

Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an “easy guide” to receptor pharmacology

CHINI, B., MANNING, M., & GUILLON, G. (2008) · Progress in Brain Research

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 65

Vasopressin: A potent autocrine/paracrine regulator of mammal adrenal functions.

Guillon, G., Grazzini, E., Andrez, M., Breton, C., Trueba, M., Gal, C. S.-L., Boccara, G., Derick, S., Chouinard, L., & Gallo-payet, N. (1998) · Endocrine Research

Neuropeptides and Animal PhysiologyCardiovascular, Neuropeptides, and Oxidative Stress Research

Cited by 55

Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model

Borie, A. M., Dromard, Y., Guillon, G., Olma, A., Manning, M., Muscatelli, F., Desarménien, M. G., & Jeanneteau, F. (2021) · Journal of Clinical Investigation

Neuroendocrine regulation and behaviorGenetics and Neurodevelopmental Disorders

Cited by 41

Hypothalamic vasopressin release and hepatocyte Ca 2+ signaling during liver regeneration: an interplay stimulating liver growth and bile flow

Nicou, A., Serrière, V., Prigent, S., Boucherie, S., Combettes, L., Guillon, G., Alonso, G., & Tordjmann, T. (2003) · The FASEB Journal

Liver physiology and pathologyOrgan Transplantation Techniques and Outcomes

Cited by 38